For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails Email * SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A major global pharmaceutical firm said its decision to back out of a £1bn research hub partway through construction is because the UK is “not internationally competitive”.
The move by US-based firm Merck, known as MSD across Europe, is the latest setback for Britain, despite Labour having put life sciences as a key pillar to support across business in the new industrial strategy earlier this year.
A government spokesperson said the UK “has become the most attractive place to invest in the world”, but that was dismissed by a statement from Merck, whic
Continue Reading on The Independent
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.